Microambient en la patogènesi i teràpia del limfoma
Projectes destacats
-
Tailored immunotherapies in 3D models of Follicular Lymphoma (TAIFOL)
Investigador/a principal: Patricia Pérez Galán.Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació La Marató de TV3 .Durada: 01/04/2020Characterization of duvelisib activity in follicular lymphoma and macrophages crosstalk
Investigador/a principal: Patricia Pérez Galán.Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Verastem .Durada: 01/01/2020 - 31/12/2020Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET
Investigador/a principal: Patricia Pérez Galán, Maria Cinta Cid Xutgla, Patricia Pérez Galán.Finançador: Ministerio de Economia y Competitividad (MINECO) (Patrocinador).Codi: SAF 2017- 88275-R.Durada: 01/01/2018 - 31/12/2020Cross-border network of personalized immunotherapies in Non-Hodgkin Lymphoma -IMLINFO (POCTEFA-INTERREG). Proyecto financiado por Fondo Europeo de Desarrollo Regional (FEDER)
Investigador/a principal: Patricia Pérez Galán.Finançador: INTERREG V-POCTEFA .Codi: EFA281/16.Durada: 01/01/2018 - 31/12/2021MICROENTARGET: Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention.
Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); MINECO .Durada: 01/12/2017Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention
Investigador/a principal: Patricia Pérez Galán.Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Ministerio de Economia y Competitividad (MINECO) ; PROYECTOS I+D+I RETOS INVESTIGACIÓN (Programa financiador competitivo).Codi: SAF2014-57708-R.Durada: 01/10/2015 - 30/09/2018Characterization of the mechanisms of microenvironment-derived resistance to GS-1101/ Idelalisib in follicular lymphoma. Analysis of therapeutic potential combination with other kinases inhibitors
Investigador/a principal: Patricia Pérez Galán.Finançador: Gilead .Durada: 01/07/2014HuMax-CD38 (Daratumumab) activity in in vivo models of MCL and FL: Analysis of possible combinatorial regimens
Investigador/a principal: Patricia Pérez Galán.Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Janssen Pharmaceuticals .Durada: 01/06/2014Targeting proliferation and tumor-microenvironment interactions using bifunctional compounds against cannabinoid and chemokine receptors
Investigador/a principal: Patricia Pérez Galán.Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundacio la Marato TV3 ; http://www.tv3.cat/marato/es/projectes_financats_2012 (Programa financiador competitivo).Durada: 26/05/2014 - 26/05/2017Microenvironment Interactions in the pathogenesis of lymphoid neoplasms and chronic inflammatory disorders. Identification of biomarkers and design of new therapeutic strategies
Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III ; Proyectos transversales ISCIII (Programa financiador competitivo).Codi: PIE1313/00033.Durada: 01/03/2014 - 01/03/2017Finançadors principals
La recerca d'aquest grup es pot dur a terme gràcies als finançadors.
Més sobre recercaConsulta les ofertes de feinaL'IDIBAPS busca professionals amb talent per cobrir les necessitats que sorgeixen de forma periòdica.
Entra